[
フレーム]
Please make JavaScript on and see this site.
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
-
Information for approved products in Japan
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
-
Regulations and services of PMDA
Information for approved products in Japan
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Reviews and Related Services
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety Measures
Regulatory Science/The Science Board/Standard Development
The 5th Subcommittee on Rare Cancers
Press Release
Date and Time:June 30, 2017 from 4pm to 6pm
Agenda / List of Handouts
Agenda
- Promoting Rare Cancers Control and Drug Development – from Doctor's Position and Patient's Position- (Dr. Kazuhiro Sase, Juntendo University)
- Interim Report -Including Overseas Situation- (Dr. Shinya Kimura, a Member of the Subcommittee)
- Presentation from Reports Each Section Representative
- Points to Consider and Future Plan
List of Handouts
- Document 1 The 4th Subcommittee Minutes Summary
- Document 2 The 1st-4th Subcommittee Discussion Summary
- Document 3 Lecture Materials (Dr. Kazuhiro Sase)
- Document 4 Lecture Materials (Dr. Shinya Kimura, a Member)
- Document 5 Rare Cancer Related Reports Overseas
- Document 6 Descriptive Guidelines for Report